“As part of a treatment plan for prostate cancer, President Biden is currently undergoing radiation therapy and hormone ...

Can Pfizer’s GDF15-blocking, appetite-boosting antibody ponsegromab address a cancer-induced wasting syndrome — and help ...

A targeted cancer drug niraparib, used in combination with hormone therapy, was found to reduce the risk of prostate tumor ...

Researchers have cracked the code behind how plants make mitraphylline, a rare cancer-fighting molecule. Their discovery of ...

EXECUTIVE CHAIRMAN & CEO OF MEDICUS TO PARTICIPATE IN A PANEL DISCUSSION The Summit theme “unlocking the $1 Trillion Wealth transfer in Dubai” PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / October 7, ...

The FDA approved a subcutaneous formulation of the blockbuster cancer drug pembrolizumab (Keytruda Qlex) for use across the drug's numerous solid tumors indications. The new formulation combines ...

A UCLA study shows that a new treatment combining radioactive drug with radiation therapy could help delay hormone therapy ...

1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. 2Harvard Medical School, Boston, Massachusetts. 3The Broad Institute of MIT and ...

As GLP-1 medications like Ozempic and Wegovy become more commonly used to treat obesity, new research is showing that having a certain gene might make it more likely for the drug to be successful. The ...

COLORADO SPRINGS, Colo. (KRDO) -- September is prostate cancer awareness month, a time to focus on one of the most common cancers affecting men. The American Cancer Society estimates more than 300,00 ...

The final, formatted version of the article will be published soon. The development of therapy resistance and the formation of distant metastases represent clinical unmet needs for patients with ...

Metastatic castration-resistant prostate cancer (mCRPC) is an aggressive subtype of prostate cancer (PC) without curative treatments. Antibody-drug conjugates (ADCs) emerged as promising cancer ...